Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite

Victor O Popoola1, Alicia Budd, Sara M Wittig

  • 1Department of Pediatrics, Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) control in neonatal intensive care units (NICUs) is challenging. Current strategies are inadequate, as infections occur before detection or after decolonization attempts, necessitating improved detection and treatment.

Area of Science:

  • Neonatalogy
  • Infectious Diseases
  • Epidemiology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat in neonatal intensive care units (NICUs).
  • Effective control strategies are crucial to prevent MRSA transmission and infection in vulnerable neonates.

Purpose of the Study:

  • To characterize the epidemiology of MRSA transmission and infections in a level IIIC NICU.
  • To identify barriers to successful MRSA control within the NICU setting.

Main Methods:

  • A retrospective cohort study was conducted in a university-affiliated NICU.
  • Neonates underwent admission and weekly nares cultures; MRSA colonization/infection, decolonization compliance, and strain relatedness (PFGE) were assessed.

Main Results:

  • Of 3,536 neonates, 2.0% acquired MRSA, with 26% of colonized neonates developing infection.
  • Infections occurred before MRSA identification or post-decolonization; 50% of neonates in the NICU for ≥21 days became recolonized.
  • USA300 was the most prevalent MRSA strain (31%).

Conclusions:

  • Current MRSA prevention strategies, including active surveillance and decolonization, are insufficient.
  • Neonates can develop MRSA infections before detection or after decolonization attempts.
  • Future efforts should focus on enhanced MRSA detection, optimized decolonization, and interrupting transmission reservoirs.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219